Effect of Desflurane Versus Sevoflurane With Recent Bio-markers on Renal and Hepatic Functions

NCT05027191 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2021-08-30

No results posted yet for this study

Summary

Studying the effects of both inhalational anesthetics desflurane and sevoflurane on hepatic integrity and renal function, guided by recent blood and urine biomarkers in patients undergoing laparoscopic cholecystectomy surgery.

Conditions

  • Postoperative Complications

Interventions

DIAGNOSTIC_TEST

Neutrophil Gelatinase-Associated Lipocalin (NGAL)

The evaluation of inhalational anesthetics (desflurane and sevoflurane) on NGAL levels in laparoscopic cholecystectomy patients.

DRUG

Desflurane

Desflurane

DRUG

Sevoflurane

Sevoflurane

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER
  • Theodor Bilharz Research Institute

    lead OTHER

Principal Investigators

  • Khalda G Radwan, MD · Theodor Bilharz Rsearch Institute

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-15
Primary Completion
2019-11-20
Completion
2019-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05027191 on ClinicalTrials.gov